Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
4.880
-0.260 (-5.06%)
At close: Jun 18, 2026, 4:00 PM EDT
4.990
+0.110 (2.25%)
After-hours: Jun 18, 2026, 6:30 PM EDT
Alterity Therapeutics Employees
Alterity Therapeutics had 9 employees as of June 30, 2025. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
$491,849
Profits / Employee
-$1,081,343
Market Cap
91.50M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 9 | -1 | -10.00% |
| Jun 30, 2024 | 10 | -1 | -9.09% |
| Jun 30, 2023 | 11 | -1 | -8.33% |
| Jun 30, 2022 | 12 | 1 | 9.09% |
| Jun 30, 2021 | 11 | -1 | -8.33% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Seer, Inc. | 124 |
| Inovio Pharmaceuticals | 112 |
| Verrica Pharmaceuticals | 76 |
| PolyPid | 75 |
| Cue Biopharma | 29 |
| NeurAxis | 24 |
| Black Diamond Therapeutics | 21 |
ATHE News
- 5 days ago - Alterity Therapeutics assumed with a Buy at Ladenburg - TheFly
- 6 days ago - Alterity Therapeutics Slides: Corporate presentation - Filings
- 11 days ago - Alterity Aligns With FDA On Phase 3 Design For ATH434 In Treating Multiple System Atrophy - Nasdaq
- 12 days ago - Alterity Therapeutics (ATHE) Gets FDA Nod for Phase 3 Program - GuruFocus
- 12 days ago - Alterity Therapeutics (ATHE) Secures FDA Agreement for Phase 3 ATH434 Trial - GuruFocus
- 12 days ago - Alterity Therapeutics achieves alignment with FDA on program for ATH434 in MSA - TheFly
- 12 days ago - Alterity Therapeutics Achieves Alignment with U.S. FDA on Pivotal Phase 3 Program for ATH434 in Multiple System Atrophy - GlobeNewsWire
- 18 days ago - Alterity Therapeutics management to meet with BTIG - TheFly